Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Concord Molecular Medicine Laboratory, |
RCV005059598 | SCV005088566 | likely pathogenic | Epilepsy with myoclonic atonic seizures | 2024-07-25 | criteria provided, single submitter | clinical testing | This single nucleotide deletion generates a frame shift starting at codon Met332. The new reading frame ends in a STOP codon at position 41, p.(Met332Cysfs*41). It is predicted to be subject to nonsense mediated decay. Loss of function is a known mechanism of disease (gnomAD pLoF: 0.15). This variant is absent from control population (gnomAD v4.1.0), and has not been previously reported. Pathogenic truncating variants both upstream and downstream of this variant have been reported in patients with SLC6A1 -related NDD (PMID: 25865495). |